Pediatric Rheumatologist Explains Many New Updates to ACR’s Juvenile Idiopathic Arthritis Guidelines
The new draft guidelines favor earlier DMARD therapy with ‘much decreased reliance on glucocorticoids that have several side effects in growing children,’ said rheumatologist Susan Shenoi, MS.
Please provide your email address to receive an email when new articles are posted on . Biologic disease-modifying antirheumatic drugs used to treat juvenile rheumatic diseases are excluded entirely ...
rheumatoid arthritis dmard vs biologic Updated American College of Rheumatology recommendations suggest using first-line DMARDs in combination with biologic agents and nonbiologic DMARDs to achieve ...
A study conducted in Denmark showed that treatment of rheumatoid arthritis with disease modifying antirheumatic drugs (DMARDs), glucocorticoids, biologic agents, or a combination of agents ...
SAN DIEGO — Disease-modifying antirheumatic drugs (DMARDs) and biologics were linked to as much as a 74.5% reduction in the risk for alopecia areata (AA) in patients with psoriasis, a new ...
ROCKVILLE, Md., Sept. 26, 2011 /PRNewswire-USNewswire/ -- Medications known as disease-modifying anti-rheumatic drugs, or DMARDs, appear to be more effective than other treatments for children with ...
rheumatoid arthritis The analysis focused on comparing the benefits and risks of biologic monotherapy, non-TNF agents, or tofacitinib monotherapy vs. placebo or methotrexate/other DMARDs. According to ...
One of the most talked about treatments for rheumatoid arthritis (RA) involves the use of disease-modifying antirheumatic drugs or DMARDs. Studies show these medications can actually halt the ...
When the symptoms of psoriatic arthritis (PsA) are severe, doctors often turn to disease-modifying antirheumatic drugs (DMARDs) for treatment. These drugs alleviate the symptoms of psoriatic arthritis ...
Advances in medication have changed ankylosing spondylitis treatment and may even change the progression of the disease. That’s welcome news for many people who deal with the pain and stiffness of ...
The treat-to-target approach represented a stepped-up model for chronic disease management that only became possible when the available therapies showed the potential for disease remission. The ...
One of the most talked about treatments for rheumatoid arthritis (RA) involves the use of disease-modifying antirheumatic drugs or DMARDs. Studies show these medications can actually halt the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results